Developing advanced tests for monitoring Type 1 diabetes in children
Robust Mass Spectrometric Protein/Peptide Assays for Type 1 Diabetes Clinical Applications
This study is working on new, more accurate tests to measure important proteins and hormones in kids and young adults with Type 1 diabetes, so doctors can better track how the disease is progressing and how well treatments are working.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Battelle Pacific Northwest Laboratories NIH-funded |
| Lab location | 1 site (Richland, United States) |
| Project ID | NIH-10891667 on NIH RePORTER |
What this research studies
This research focuses on creating reliable tests that measure specific proteins and hormones related to Type 1 diabetes (T1D) in children and young adults. By using advanced mass spectrometry techniques, the project aims to develop assays that can accurately track disease progression and the effectiveness of treatments. These tests will provide crucial information about the body's insulin and glucagon levels, helping healthcare providers make informed decisions about patient care. The goal is to improve monitoring methods that currently rely heavily on less precise antibody-based tests.
Who could benefit from this research
Good fit: Ideal candidates for this research are children and young adults diagnosed with Type 1 diabetes.
Not a fit: Patients with Type 2 diabetes or other forms of diabetes may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more accurate monitoring of Type 1 diabetes, allowing for better management and treatment options for affected children.
How similar studies have performed: Previous research has shown promise in using mass spectrometry for similar applications, indicating potential for success in this novel approach.
Where this research is happening
Richland, United States
- Battelle Pacific Northwest Laboratories — Richland, United States (Active)
Researchers
- Principal investigator: Qian, Wei-Jun — Battelle Pacific Northwest Laboratories
- Study coordinator: Qian, Wei-Jun
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.